Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Clinical Trial

Randomized Controlled Trial

Research Support, U.S. Gov't, P.H.S.

Controlled Clinical Trial

Research Support, N.I.H., Extramural

Comparative Study

Research Support, N.I.H., Intramural

Meta-Analysis

Case Reports

Clinical Trial, Phase I

Multicenter Study

Publication Year

From

Quick links

Individual year

2024

2023

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""fas Receptor""[mesh_terms]

79 Results

Searching titles within these results

Fas (CD95)/FasL (CD178) system during ageing.

Francisco A Lagunas-Rangel

Cell biology international 2023;47(8):1295-1313

Full Text

Abstract

Does calcium contribute to the CD95 signaling pathway?

Patrick Legembre, Pierre Vacher, Nadine Khadra, Anne-Marie Vacher, Laurence Bresson-Bepoldin, Emilie Charles

Anti-cancer drugs 2011;22(6):481-7

Full Text

Abstract

Alterations in Fas (CD 95/Apo-1) and Fas ligand (CD178) expression in acute promyelocytic leukemia during treatment with ATRA.

Helmut R Salih, Peter A Kiener

Leukemia & lymphoma 2004;45(1):55-9

Full Text

Abstract

Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome.

Cécile Masson, Pierre Quartier, Nathalie Neveux, Jérémie Rosain, Marion Malphettes, Capucine Picard, Frédéric Rieux-Laucat, Filippo Consonni, Solange Moreno, Blanca Vinuales Colell, Marie-Claude Stolzenberg, Alicia Fernandes, Mélanie Parisot, Sarah Bamberger, Marie-Gabrielle Vigue, Aude Magerus

Cell death & disease 2024;15(5):315

Free Full Text

Abstract

Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer.

Gokhan Demir, H O Klein, Nil Mandel-Molinas, N Tuzuner

International immunopharmacology 2007;7(1):113-6

Full Text

Abstract

Recruitment of cellular prion protein to mitochondrial raft-like microdomains contributes to apoptosis execution.

Vincenzo Mattei, Paola Matarrese, Tina Garofalo, Antonella Tinari, Lucrezia Gambardella, Laura Ciarlo, Valeria Manganelli, Vincenzo Tasciotti, Roberta Misasi, Walter Malorni, Maurizio Sorice

Molecular biology of the cell 2012;22(24):4842-53

Free Full Text

Abstract

Dissecting lipid raft facilitated cell signaling pathways in cancer.

Samir Kumar Patra

Biochimica et biophysica acta 2008;1785(2):182-206

Full Text

Abstract

Evading apoptosis by calcitriol-differentiated human leukemic HL-60 cells is not mediated by changes in CD95 receptor system but by increased sensitivity of these cells to insulin.

A Wiedłocha, E Marcinkowska, A Chrobak

Experimental cell research 2001;270(1):119-27

Full Text

Abstract

Sketching of CD95 Oligomers by In Silico Investigations.

Nicolas Levoin

Methods in molecular biology (Clifton, N.J.) 2018;1557():153-171

Full Text

Abstract

Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.

Francesco Puppo, Paola Contini, Massimo Ghio, Francesco Indiveri

TheScientificWorldJournal 2004;2():421-3

Free Full Text

Abstract

Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon alpha: involvement of tumor necrosis factor as ligand for the CD95 receptor.

H Gisslinger, R Kurzrock, B Gisslinger, S Jiang, S Li, I Virgolini, W Woloszczuk, M Andreeff, M Talpaz

Blood 2001;97(9):2791-7

Free Full Text

Abstract

GnRH receptor and apoptotic signaling.

T Tamaya, A Imai

Vitamins and hormones 2000;59():1-33

Full Text

Abstract

Construction of optimized bispecific antibodies for selective activation of the death receptor CD95.

Tanja Herrmann, Ludger Grosse-Hovest, Tina Otz, Peter H Krammer, Hans-Georg Rammensee, Gundram Jung

Cancer research 2008;68(4):1221-7

Full Text

Abstract

The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuli.

Steven de Jong, Edo Vellenga, Elisabeth G E de Vries, Diana C J Spierings

The Journal of pathology 2003;200(2):137-48

Full Text

Abstract

CD95/Fas and metastatic disease: What does not kill you makes you stronger.

Patrick Legembre, Pierre Vacher, Jean-François Quignard, Thomas Ducret, Emmanuelle Charafe-Jauffret, Christophe Ginestier, Jean Philippe Guégan

Seminars in cancer biology 2020;60():121-131

Free Full Text

Abstract

Results: 1 – 15 / 79

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""fas Receptor""[mesh_terms]

Fas (CD95)/FasL (CD178) system during ageing.

Does calcium contribute to the CD95 signaling pathway?

Alterations in Fas (CD 95/Apo-1) and Fas ligand (CD178) expression in acute promyelocytic leukemia during treatment with ATRA.

Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome.

Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer.

Recruitment of cellular prion protein to mitochondrial raft-like microdomains contributes to apoptosis execution.

Dissecting lipid raft facilitated cell signaling pathways in cancer.

Evading apoptosis by calcitriol-differentiated human leukemic HL-60 cells is not mediated by changes in CD95 receptor system but by increased sensitivity of these cells to insulin.

Sketching of CD95 Oligomers by In Silico Investigations.

Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.

Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon alpha: involvement of tumor necrosis factor as ligand for the CD95 receptor.

GnRH receptor and apoptotic signaling.

Construction of optimized bispecific antibodies for selective activation of the death receptor CD95.

The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuli.

CD95/Fas and metastatic disease: What does not kill you makes you stronger.

Results for
""fas Receptor""[mesh_terms]